Delivery Order SPE2DB20D3505-SPE2DB25FT7G2

Award Date 1/3/25
Potential Completion Date 1/6/25
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $5,840.66 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of MYRBETRIQ ER 50 MG TABLET 90S. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of MYRBETRIQ ER 50 MG TABLET 90S. The $1,368.93 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,336.45, is a Firm Fixed Price Delivery Order for the supply of MYRBETRIQ ER 25 MG TABLET 30S, with a completion date of May 1, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This contract award, valued at $1,736.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MYRBETRIQ ER 50 MG TABLET 90S, a medication, and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $17,245.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,528.88, is a delivery order for the supply of MYRBETRIQ ER 25 MG TABLET 90S. The contract has an ultimate completion date of December 31, 2024 and is a Firm Fixed Price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $80,336.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of MYRBETRIQ ER 50 MG TABLET 90S. The contract is a Firm Fixed Price Delivery Order with a completion date of March 29, 2023. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $2,416.29 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of MYRBETRIQ ER 25 MG TABLET 90S, a prescription medication. This delivery order was placed under an Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued up to $999,999,999 through December 2025, for a wide range of medical commodities to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,170.87 firm fixed-price delivery order is for the supply of 4566581033 - MYRBETRIQ ER 25 MG TABLET 90S. This contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical...
This federal contract award, valued at $4,559.81, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of MYRBETRIQ ER 50 MG TABLET 90S, with an ultimate completion date of December 27, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB25FT7G2
    Delivery Order

This federal contract award SPE2DB20D3505|SPE2DB25FT7G2, valued at $2,540.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of MYRBETRIQ ER 50 MG TABLET 90S, a pharmaceutical product, to support military healthcare programs.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/4/25, 9:50 AM